Compounds > ramosetron
Page last updated: 2024-09-02

ramosetron and mebeverine

ramosetron has been researched along with mebeverine in 2 studies

Compound Research Comparison

Studies
(ramosetron)		Trials
(ramosetron)		Recent Studies (post-2010)
(ramosetron)		Studies
(mebeverine)		Trials
(mebeverine)		Recent Studies (post-2010) (mebeverine)
19494831384845

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bak, YT; Choi, MK; Choi, SC; Huh, KC; Kim, NY; Kwon, JK; Lee, JS; Lee, KJ; Lee, OY; Myung, SJ; Park, HJ; Rhee, PL; Sohn, CI1
Clavé, P1

Trials

1 trial(s) available for ramosetron and mebeverine

ArticleYear
Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
    Neurogastroenterology and motility, 2011, Volume: 23, Issue:12

    Topics: Adolescent; Adult; Benzimidazoles; Diarrhea; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Parasympatholytics; Phenethylamines; Republic of Korea; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Young Adult

2011

Other Studies

1 other study(ies) available for ramosetron and mebeverine

ArticleYear
Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets.
    Neurogastroenterology and motility, 2011, Volume: 23, Issue:12

    Topics: Benzimidazoles; Diarrhea; Humans; Irritable Bowel Syndrome; Male; Parasympatholytics; Phenethylamines; Serotonin 5-HT3 Receptor Antagonists

2011